Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-21-003321

Chief Medical Officer acquired 224,529 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schwartz Jonathan David · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Exercise or conversion : show line 1 in the form +11,428 $1.69 $19,313 11,428 D
2021-02-01 Exercise or conversion : show line 2 in the form +213,101 $1.21 $257,852 224,529 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-01 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −11,428 $1.69 2027-04-12 11,428 0 D
2020-02-10 Returned to the company : show line 4 in the form Stock Option (Right to Buy) −213,101 $1.21 2026-02-08 213,101 38,309 D
Loading xslF345X03/form4.xml…